Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    CT1812

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cognition Therapeutics' CT1812 Study Results Accepted For AAIC Presentation
    Cognition Therapeutics' CT1812 Study Results Accepted For AAIC Presentation

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907325/0/en/Results-from-Cognition-Therapeutics-Phase-2-SHINE-Study-of-CT1812-in-Mild-to-Moderate-Alzheimer-s-Disease-Accepted-for-Presentation-at-AAIC.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Cognition Completes Enrollment in SHIMMER Phase 2 for DLB
    Cognition Completes Enrollment in SHIMMER Phase 2 for DLB

    29 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/29/2871142/0/en/Cognition-Therapeutics-Completes-Enrollment-in-Phase-2-SHIMMER-Study-of-CT1812-in-Mild-to-Moderate-Dementia-with-Lewy-Bodies.html

    GLOBENEWSWIRE
    29 Apr 2024
    Share Share